Incorrect, LOOK Hard at the Deal... and don't forget 10% OID
"Look hard at the deal the stock issuances are not discounted and in any way NOT considered toxic which some folks are pointing at and misleading the public"
On February 15, 2018, the Company drew down a second tranche against the Chicago Venture note in the amount of
$636,304. Note proceeds of $586,304 were received from Chicago Venture, which was net of a $50,000 commitment
fee paid to Chicago Venture. The second tranche is evidenced by secured convertible promissory notes that are
subject to the same repayment and conversion terms as the first tranche and bear interest at 10%. The second
tranche on the Chicago Venture note matured in October 2018. Note principal and accrued interest on the second
tranche was repaid by the Company during the nine months ended September 30, 2018 in the following manner:
$50,000 was paid through the issuance of 2,488,800 shares of common stock valued at $0.02 per share; $300,000 was
paid through the issuance of 6,000,000 shares of common stock valued at $0.05 per share; $100,000 was paid through
the issuance of 2,184,360 shares of common stock valued at $0.046 per share; $50,000 was paid through the issuance
of 1,077,354 shares of common stock valued at $0.046 per share; $75,000 was paid through the issuance of 1,778,811
shares of common stock valued at $0.042 per share; and $76,055 was paid through the issuance of 1,974,279 shares of
common stock valued at $0.039 per share. The balance outstanding on the second tranche was $0 at September 30,
2018. Accrued interest on the second tranche at June 30, 2018 was $1,040
News 
Market Data 
Discover 
